F Dx Advisors, Inc. Boston Scientific Corp Transaction History

F Dx Advisors, Inc.

$308 Million
Q1 2025

A detailed history of F Dx Advisors, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, F Dx Advisors, Inc. holds 4,120 shares of BSX stock, worth $423,824. This represents 0.14% of its overall portfolio holdings.

Number of Shares

4,120

Previous 5,759 28.46%

Holding current value

$423,824

Previous $514,000 19.07%

% of portfolio

0.14%

Previous 0.15%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$89.38 - $106.18 $146,493 - $174,029	-1,639 Reduced 28.46%	4,120 $416,000
Q4 2024 Feb 03, 2025	SELL	$83.62 - $91.5 $52,011 - $56,913	-622 Reduced 9.75%	5,759 $514,000
Q3 2024 Nov 04, 2024	SELL	$72.96 - $84.0 $79,818 - $91,896	-1,094 Reduced 14.64%	6,381 $535,000
Q2 2024 Aug 02, 2024	SELL	$67.33 - $77.71 $118,231 - $136,458	-1,756 Reduced 19.02%	7,475 $576,000
Q1 2024 May 03, 2024	SELL	$57.6 - $68.62 $254,764 - $303,506	-4,423 Reduced 32.39%	9,231 $632,000
Q4 2023 Feb 12, 2024	SELL	$48.64 - $57.81 $174,666 - $207,595	-3,591 Reduced 20.82%	13,654 $789,000
Q3 2023 Nov 02, 2023	BUY	$50.19 - $54.68 $21,129 - $23,020	421 Added 2.5%	17,245 $910,000
Q2 2023 Jul 17, 2023	BUY	$49.72 - $54.64 $390,351 - $428,978	7,851 Added 87.5%	16,824 $910,000
Q4 2022 Feb 09, 2023	BUY	$39.56 - $47.22 $41,063 - $49,014	1,038 Added 13.08%	8,973 $415,000
Q3 2022 Nov 10, 2022	SELL	$36.71 - $109.66 $99,410 - $296,959	-2,708 Reduced 25.44%	7,935 $307,000
Q2 2022 Aug 03, 2022	BUY	$35.24 - $47.1 $63,114 - $84,356	1,791 Added 20.23%	10,643 $397,000
Q1 2022 May 03, 2022	SELL	$40.9 - $45.1 $151,616 - $167,185	-3,707 Reduced 29.52%	8,852 $392,000
Q4 2021 Feb 01, 2022	BUY	$38.07 - $44.87 $125,364 - $147,756	3,293 Added 35.54%	12,559 $534,000
Q3 2021 Oct 08, 2021	BUY	$41.23 - $45.88 $42,590 - $47,394	1,033 Added 12.55%	9,266 $402,000
Q2 2021 Aug 05, 2021	BUY	$38.58 - $44.24 $317,629 - $364,227	8,233 New	8,233 $352,000
Q4 2020 Feb 08, 2021	SELL	$33.15 - $41.97 $1.17 Million - $1.48 Million	-35,360 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$34.44 - $42.23 $275,520 - $337,840	8,000 Added 29.24%	35,360 $1.35 Million
Q2 2020 Jul 22, 2020	BUY	$30.19 - $39.11 $510,935 - $661,897	16,924 Added 162.17%	27,360 $961,000
Q1 2020 May 22, 2020	SELL	$25.83 - $45.71 $123,157 - $217,945	-4,768 Reduced 31.36%	10,436 $341,000
Q1 2020 May 13, 2020	SELL	$25.83 - $45.71 $52,150 - $92,288	-2,019 Reduced 11.72%	15,204 $22,000
Q4 2019 Feb 12, 2020	BUY	$37.87 - $45.37 $237,823 - $284,923	6,280 Added 57.39%	17,223 $779,000
Q3 2019 Nov 07, 2019	SELL	$40.31 - $43.45 $32,409 - $34,933	-804 Reduced 6.84%	10,943 $445,000
Q2 2019 Jul 19, 2019	SELL	$34.91 - $42.98 $14,522 - $17,879	-416 Reduced 3.42%	11,747 $505,000
Q1 2019 May 14, 2019	SELL	$32.91 - $40.75 $32 - $40	-1 Reduced 0.01%	12,163 $467,000
Q4 2018 Apr 29, 2019	SELL	$31.73 - $39.04 $48,388 - $59,536	-1,525 Reduced 11.14%	12,164 $430,000
Q4 2018 Feb 07, 2019	BUY	$31.73 - $39.04 $84,909 - $104,471	2,676 Added 24.3%	13,689 $484,000
Q3 2018 Nov 13, 2018	SELL	$32.83 - $38.63 $45,994 - $54,120	-1,401 Reduced 11.29%	11,013 $424,000
Q2 2018 Aug 08, 2018	SELL	$26.84 - $34.32 $76,225 - $97,468	-2,840 Reduced 18.62%	12,414 $406,000
Q1 2018 May 02, 2018	SELL	$25.2 - $28.54 $110,779 - $125,461	-4,396 Reduced 22.37%	15,254 $417,000
Q4 2017 Feb 09, 2018	BUY	$24.79 - $29.8 $37,879 - $45,534	1,528 Added 8.43%	19,650 $487,000
Q3 2017 Nov 03, 2017	BUY	$26.26 - $29.17 $34,768 - $38,621	1,324 Added 7.88%	18,122 $529,000
Q2 2017 Aug 11, 2017	BUY	N/A	16,798	16,798 $466,000

Others Institutions Holding BSX

# of Institutions

1,727

Shares Held

1.18B

Call Options Held

8.69M

Put Options Held

9.13M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account